Spetzler-Martin grade III brain arteriovenous malformations (bAVMs) treatment, regardless of the exclusion method selected, may prove demanding. Evaluation of endovascular treatment's (EVT) safety and efficacy as a first-line therapy for SMG III bAVMs was the objective of this study.
The authors performed an observational cohort study, a retrospective analysis conducted at two centers. A detailed examination of cases, as recorded within institutional databases between January 1998 and June 2021, was undertaken. For the study, those patients who met the criteria of being 18 years of age, with either ruptured or unruptured SMG III bAVMs, and had received EVT as the initial treatment were included. The study assessed baseline characteristics of patients and their bAVMs, procedure-related complications, clinical outcomes based on the modified Rankin Scale, and angiographic follow-up data. The independent risk factors for procedure-related complications and poor clinical results were investigated using the binary logistic regression method.
A group of 116 patients, all bearing the SMG III bAVMs diagnosis, were part of the study. The patients' ages had an average of 419.140 years. A prominent presentation, encompassing 664%, was hemorrhage. see more At the follow-up visit, forty-nine (422%) bAVMs were found to have been completely destroyed solely through the EVT procedure. Complications affected 39 patients (336% prevalence), 5 of whom (43%) experienced major procedure-related complications. There was no single, independent element that could forecast procedure-related complications. Patients older than 40 and exhibiting a poor preoperative modified Rankin Scale score independently predicted a less favorable clinical outcome.
The EVT of SMG III bAVMs demonstrates positive outcomes, but continued work is needed for enhanced effectiveness. Embolization, when aimed at a cure, if deemed difficult or risky, could benefit from the combined use of microsurgery or radiosurgery for a safer and more efficacious result. The safety and effectiveness of EVT, employed alone or within a multifaceted treatment approach, for SMG III bAVMs, necessitates verification through randomized controlled trials.
Preliminary findings from the SMG III bAVMs EVT study are promising but require additional investigation. Given the potential complications and/or risks inherent in an embolization procedure designed for a curative outcome, a combined intervention, integrating microsurgery or radiosurgery, could provide a safer and more powerful therapeutic modality. Randomized, controlled trials are necessary to firmly establish the advantages of EVT, including its impact on both safety and effectiveness, in the management of SMG III bAVMs, whether used in isolation or alongside other treatment modalities.
As a standard practice, neurointerventional procedures often employ transfemoral access (TFA) for vascular entry. A percentage of patients (2% to 6%) can experience complications stemming from the femoral access site. Handling these complications usually mandates further diagnostic examinations or treatments, leading to a rise in the expense of care. The economic ramifications of femoral access site complications remain undocumented. This investigation sought to evaluate the financial ramifications of femoral access site complications.
Through a retrospective review at their institution, the authors determined which patients undergoing neuroendovascular procedures experienced complications at the femoral access site. For every 12 patients experiencing complications during elective procedures, a corresponding patient without such complications during a comparable procedure was selected as part of a control group.
In a three-year study, femoral access site complications were found in 77 patients, comprising 43% of the sample. Major complications, demanding blood transfusions or further invasive procedures, comprised thirty-four instances of these issues. A statistically significant disparity in total expenditure was observed, amounting to $39234.84. In relation to a price of $23535.32, A p-value of 0.0001 was associated with a total reimbursement of $35,500.24. Considering similar options, this item is priced at $24861.71. Significant differences were observed in reimbursement minus cost between complication and control cohorts in elective procedures (p = 0.0020) and (p = 0.0011), respectively, with complication cohort showing -$373,460 compared to the control cohort's $132,639.
Although not prevalent, complications stemming from femoral artery access sites in neurointerventional procedures correlate with escalating patient care costs; the impact of these complications on the cost-efficiency of neurointerventional procedures deserves further examination.
While femoral artery access is relatively uncommon, complications at the access site can elevate the expense of care for patients undergoing neurointerventional procedures; further study is needed to determine the impact on the cost-effectiveness of these procedures.
The presigmoid corridor's therapeutic options encompass a spectrum of strategies utilizing the petrous temporal bone. This bone serves as either a treatment site for intracanalicular lesions or a pathway to the internal auditory canal (IAC), the jugular foramen, or the brainstem. Continuous development and refinement of complex presigmoid approaches have led to a wide range of varying definitions and descriptions. see more In light of the common use of the presigmoid corridor in lateral skull base procedures, an easily understood, anatomy-based classification system is required to define the operative perspective of the different presigmoid route configurations. The authors reviewed the literature with a scoping approach, aiming to develop a categorization system for presigmoid approaches.
From inception to December 9, 2022, a search was conducted across PubMed, EMBASE, Scopus, and Web of Science databases, adhering to PRISMA Extension for Scoping Reviews guidelines, to identify clinical studies detailing the employment of standalone presigmoid approaches. Findings were synthesized to classify presigmoid approach variations, utilizing the parameters of anatomical corridor, trajectory, and targeted lesions.
Ninety-nine clinical studies were examined; vestibular schwannomas (60 cases, or 60.6% of the total) and petroclival meningiomas (12 cases, or 12.1% of the total) were the most frequently observed target lesions. A common entry point, a mastoidectomy, was used in all strategies, but they were categorized into two principal groups, based on their relationship to the labyrinthine structure: translabyrinthine or anterior corridor (80/99, 808%) and retrolabyrinthine or posterior corridor (20/99, 202%). Five subtypes of the anterior corridor were defined based on the extent of bone removal: 1) partial translabyrinthine (5 cases, 51% incidence), 2) transcrusal (2 cases, 20% incidence), 3) translabyrinthine proper (61 cases, 616% incidence), 4) transotic (5 cases, 51% incidence), and 5) transcochlear (17 cases, 172% incidence). The posterior corridor demonstrated four distinct surgical variations, each defined by the target location and trajectory in relation to the IAC: 6) retrolabyrinthine inframeatal (6/99, 61%), 7) retrolabyrinthine transmeatal (19/99, 192%), 8) retrolabyrinthine suprameatal (1/99, 10%), and 9) retrolabyrinthine trans-Trautman's triangle (2/99, 20%).
Presigmoid approaches are experiencing a rise in complexity due to the expanding use of minimally invasive procedures. Characterizing these approaches with the present lexicon can be imprecise or ambiguous. Consequently, the authors propose a comprehensive anatomical framework for classifying presigmoid approaches, one that is clear, concise, and effective.
The rise of minimally invasive procedures is intricately linked to the growing complexity of presigmoid techniques. The existing terminology's descriptions of these methods can be unclear or inaccurate. The authors, accordingly, propose a detailed anatomical classification that clearly defines presigmoid approaches with simplicity, precision, and effectiveness.
Anterolateral approaches to the skull base, along with their documented effects on the temporal branches of the facial nerve (FN), have been frequently discussed in the neurosurgical literature for their bearing on frontalis palsies. The authors of this study investigated the structural characteristics of the temporal branches of the facial nerve and examined the potential for any of these branches to penetrate the interfascial plane formed by the superficial and deep layers of the temporalis fascia.
On 5 embalmed heads, having 10 extracranial facial nerves (n = 10), the bilateral surgical anatomy of the temporal branches of the facial nerve (FN) was studied. The anatomical relationships of the FN's branches, along with their connections to the encompassing fascia of the temporalis muscle, the interfascial fat pad, surrounding nerve branches, and their ultimate terminations in the frontalis and temporalis muscles, were meticulously documented via careful dissections. The authors intraoperatively correlated their findings with six consecutive patients who underwent interfascial dissection. Neuromonitoring was utilized to stimulate the FN and its accompanying branches, which were observed to lie in the interfascial plane in two of these cases.
The superficial temporal branches of the facial nerve, lying predominantly above the superficial sheet of temporal fascia, are found within the loose areolar connective tissue near the superficial fat pad. see more Branching off in the frontotemporal area, they send a twig that joins with the zygomaticotemporal branch of the trigeminal nerve, which then passes through the temporalis muscle's superficial layer, traversing the interfascial fat pad, and finally penetrates the temporalis fascia's deep layer. Dissecting 10 FNs, the anatomy in question was present in all 10 instances examined. Intraoperatively, no facial muscle response was observed following stimulation of this interfascial region, with stimulation intensity up to 1 milliampere, in any patient.